Instances of Newly-diagnosed Epilepsy Expected to Rise

May 2, 2013by Greg Jones Law

According to new information, the instances of newly-diagnosed cases of epilepsy are expected to increase between 2012 and 2022.

In the EpiCast Report, the epidemiology forecast to 2022 from Research and Markets, the number of people who will be newly diagnosed with epilepsy is set to increase by more than a million. This brings the number of people who will be living with epilepsy from 17,542,651 last year to 18,565,967 by 2022. The information used to gather this estimate was examined from countries including the United Kingdom, France, Germany, Spain, Italy, Japan and the U.S. India and China were also observed. It is currently believed that these estimates are true since the method used was consistent.

Epilepsy is a condition that is already experienced by millions of people worldwide. Epilepsy is characterized by patients suffering from seizures. The condition can be quite debilitating since scientists have yet to be able to accurately predict the onset of the seizures. For now the focus is on prevention. Drugs like Topamax are used for the prevention of seizures; however, Topamax has been linked to serious side effects. Some of the side effects linked to Topamax use are birth defects in babies whose mothers take the drugs while pregnant. Children may be born with birth defects such as PPHN, spina bifida, neural tube defects, oral clefts and heart, lung and brain defects after exposure to Topamax in-utero. This makes the use of Topamax extremely dangerous for the babies of pregnant women. Women who are pregnant or of childbearing age should consult a doctor before accepting a prescription for anti-seizure medication.

If your baby was born with birth defects after in-utero exposure to Topamax, contact attorney Greg Jones today for a free consultation. I am experienced at fighting Topamax lawsuits and may be able to help you recover money for your child’s injuries.